DK32490D0 - Injicerbart vandigt farmaceutisk praeparat - Google Patents
Injicerbart vandigt farmaceutisk praeparatInfo
- Publication number
- DK32490D0 DK32490D0 DK032490A DK32490A DK32490D0 DK 32490 D0 DK32490 D0 DK 32490D0 DK 032490 A DK032490 A DK 032490A DK 32490 A DK32490 A DK 32490A DK 32490 D0 DK32490 D0 DK 32490D0
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical preparation
- injectable water
- water pharmaceutical
- injectable
- preparation
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/203,836 US4857552A (en) | 1988-06-08 | 1988-06-08 | Stable pharmaceutical composition |
| PCT/US1989/001834 WO1989011855A1 (en) | 1988-06-08 | 1989-05-04 | Stable pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK32490D0 true DK32490D0 (da) | 1990-02-07 |
| DK32490A DK32490A (da) | 1990-02-07 |
Family
ID=22755531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK032490A DK32490A (da) | 1988-06-08 | 1990-02-07 | Injicerbart vandigt farmaceutisk praeparat |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4857552A (da) |
| EP (1) | EP0403578B1 (da) |
| JP (1) | JP2552372B2 (da) |
| AU (1) | AU613196B2 (da) |
| CA (1) | CA1334001C (da) |
| DE (1) | DE68918847T2 (da) |
| DK (1) | DK32490A (da) |
| HU (1) | HUT54041A (da) |
| IL (1) | IL90551A (da) |
| MY (1) | MY104030A (da) |
| NZ (1) | NZ229410A (da) |
| WO (1) | WO1989011855A1 (da) |
| ZA (1) | ZA894344B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5405376A (en) * | 1993-08-27 | 1995-04-11 | Medtronic, Inc. | Method and apparatus for ablation |
| DE69833665T2 (de) | 1997-08-08 | 2006-11-09 | Duke University | Zusammensetzungen zur vereinfachung von chirurgischen verfahren |
| US6711436B1 (en) | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
| TWI277414B (en) * | 2001-01-12 | 2007-04-01 | Baxter Int | Esmolol formulation |
| US6310094B1 (en) * | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| CN1558755A (zh) | 2001-09-26 | 2004-12-29 | ���ع��ʹ�˾ | 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒 |
| EP1417962A1 (de) * | 2002-11-06 | 2004-05-12 | AOP Orphan Pharmaceuticals AG | Verfahren zur Herstellung eines Arzneimittels enthaltend Esmolol |
| US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| AU2014203121B2 (en) * | 2007-05-22 | 2016-04-21 | Baxter Healthcare Sa | Concentrate esmolol |
| US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| PL2234614T3 (pl) * | 2007-12-21 | 2013-03-29 | Aop Orphan Pharmaceuticals Ag | Kompozycja farmaceutyczna do pozajelitowego podawania ultrakrótko działającego antagonisty receptora beta-adrenergicznego |
| DK2480204T3 (da) | 2009-09-22 | 2014-02-03 | Vlife Sciences Technologies Pvt Ltd | Topikal formulering til diabetiske fodsår |
| ES2363964B1 (es) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados. |
| PT2512236T (pt) * | 2009-12-18 | 2016-12-29 | Metabolic Tech Inc | Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb) |
| CA2825716A1 (en) * | 2011-01-27 | 2012-08-02 | Baxter Healthcare S.A. | Use of (s) -esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
| MX2013008713A (es) * | 2011-01-27 | 2013-08-29 | Baxter Healthcare Sa | Metodos para tratar taquicarida y/o controlar la frecuencia cardiaca, minimizando y/o controlando al mismo tiempo la hipotesis. |
| US8835505B1 (en) * | 2013-03-15 | 2014-09-16 | Welgrace Research Group | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| CN104473869A (zh) * | 2014-11-20 | 2015-04-01 | 北京京科泰来科技有限公司 | 一种艾司洛尔脂肪乳及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454154A (en) * | 1981-06-23 | 1984-06-12 | American Hospital Supply Corporation | Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents |
| WO1985004580A1 (en) * | 1984-04-09 | 1985-10-24 | American Hospital Supply Corporation | Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders |
-
1988
- 1988-06-08 US US07/203,836 patent/US4857552A/en not_active Expired - Fee Related
-
1989
- 1989-05-04 JP JP1505939A patent/JP2552372B2/ja not_active Expired - Lifetime
- 1989-05-04 WO PCT/US1989/001834 patent/WO1989011855A1/en not_active Ceased
- 1989-05-04 AU AU35704/89A patent/AU613196B2/en not_active Ceased
- 1989-05-04 EP EP89905887A patent/EP0403578B1/en not_active Expired - Lifetime
- 1989-05-04 DE DE68918847T patent/DE68918847T2/de not_active Expired - Fee Related
- 1989-05-04 HU HU892994A patent/HUT54041A/hu unknown
- 1989-06-02 CA CA000601436A patent/CA1334001C/en not_active Expired - Fee Related
- 1989-06-06 MY MYPI89000762A patent/MY104030A/en unknown
- 1989-06-06 NZ NZ229410A patent/NZ229410A/xx unknown
- 1989-06-07 IL IL90551A patent/IL90551A/xx unknown
- 1989-06-08 ZA ZA894344A patent/ZA894344B/xx unknown
-
1990
- 1990-02-07 DK DK032490A patent/DK32490A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ229410A (en) | 1991-10-25 |
| EP0403578B1 (en) | 1994-10-12 |
| JPH03500658A (ja) | 1991-02-14 |
| HUT54041A (en) | 1991-01-28 |
| DE68918847D1 (de) | 1994-11-17 |
| JP2552372B2 (ja) | 1996-11-13 |
| ZA894344B (en) | 1991-02-27 |
| AU3570489A (en) | 1990-01-05 |
| EP0403578A4 (en) | 1991-07-03 |
| AU613196B2 (en) | 1991-07-25 |
| EP0403578A1 (en) | 1990-12-27 |
| IL90551A (en) | 1992-12-01 |
| US4857552A (en) | 1989-08-15 |
| IL90551A0 (en) | 1990-01-18 |
| WO1989011855A1 (en) | 1989-12-14 |
| DE68918847T2 (de) | 1995-03-16 |
| HU892994D0 (en) | 1990-11-28 |
| DK32490A (da) | 1990-02-07 |
| CA1334001C (en) | 1995-01-17 |
| MY104030A (en) | 1993-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK229489A (da) | Laegemiddeladsorbater | |
| DK489189A (da) | Farmaceutisk praeparat | |
| DE10199066I1 (de) | Pharmazeutische Zusammensetzung | |
| DK89090A (da) | Farmaceutisk praeparat | |
| DE68926627D1 (de) | Injektionsstelle | |
| DK540389A (da) | Immunstimulerende praeparat | |
| DK32490A (da) | Injicerbart vandigt farmaceutisk praeparat | |
| DK705488D0 (da) | Farmaceutisk praeparat | |
| FI893643A7 (fi) | Farmaseuttisia koostumuksia | |
| DK548689A (da) | Farmaceutisk oploesning | |
| DK603988D0 (da) | Farmaceutisk praeparat | |
| DK496889D0 (da) | Peptidholdigt farmaceutisk praeparat | |
| DK336489A (da) | Farmaceutisk praeparat | |
| DK139388A (da) | Farmaceutisk praeparat | |
| BR9006025A (pt) | Preparacao farmaceutica | |
| FI894321A7 (fi) | Terapeuttisia aineita | |
| DK276288D0 (da) | Farmaceutisk praeparat | |
| DK606288D0 (da) | Praeparat | |
| ATA321188A (de) | Pharmazeutische zubereitung | |
| DK37589A (da) | Farmaceutisk praeparat for 4-aroylimidazol-2-oner | |
| IT1224244B (it) | Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano | |
| DK638889D0 (da) | Farmaceutisk kombinationspraeparat | |
| DK343689A (da) | Herbicidt praeparat | |
| DK138888A (da) | Farmaceutisk praeparat | |
| LV5728A4 (lv) | Farmaceitiskas kompozicijas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |